Global Expansion Potential Syneos Health recently expanded offices in Pune, India, signaling growing demand for regional delivery and regulatory support. This creates an opportunity to propose local CRO and regulatory services, EU market entry support, and CMC Module 3 work to capture new client engagements in Asia-Pacific and Europe.

AI Trial Partnerships Partnerships with Helio Genomics highlight an appetite for AI-powered biology and data-enabled decision making in early cancer detection. This opens doors to offering AI-enabled trial optimization, biomarker data analytics, and predictive trial planning to accelerate development timelines.

Patient Engagement Edge Winning the MedTech Breakthrough Award for Best Mobile App demonstrates strong patient-facing digital capabilities. Leverage this strength to upsell integrated patient engagement apps, remote monitoring, recruitment and retention programs, and data-driven patient support platforms.

Integrated Solutions Syneos Health markets an end-to-end clinical and commercial solution, enabling bundled services from trial execution to market access. Use this to position cross-portfolio offerings for new or expanding programs with unified data and insights across development stages.

Data Security The tech stack includes ISO/IEC 27001 recognition and a focus on secure data handling. This provides a credible basis to address clients' needs for compliant data management, privacy, and regulatory adherence across globally distributed trials, including API governance and cloud security.